foxo4-dri senolytic peptide human trials trial Development of a novel senolytic by precise disruption of FOXO4- FOXO4-DRI induces keloid senescent fibroblast
Description
Premium research peptide for cellular health and longevity studies
This product is not intended to diagnose, treat, cure, or preventa disease
Bpc 157 Injectables at 14160.00 INR offered by Vital Science Industry is available with multiple payment options and easy delivery.
99% purity verified with batch-level COAs available
learn its benefits, uses, safety, and effectiveness.
